High-throughput isolation of Caenorhabditis elegans deletion mutants

被引:139
作者
Liu, LX
Spoerke, JM
Mulligan, EL
Chen, J
Reardon, B
Westlund, B
Sun, L
Abel, K
Armstrong, B
Hardiman, G
King, J
McCague, L
Basson, M
Clover, R
Johnson, CD
机构
[1] Axys Pharmaceut, NemaPharm Grp, San Francisco, CA 94080 USA
[2] Axys Pharmaceut, NemaPharm Grp, La Jolla, CA USA
关键词
D O I
10.1101/gr.9.9.859
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nematode Caenorhabditis elegans is the First animal whose genome is completely sequenced, providing a rich source of gene information relevant to metazoan biology and human disease. This abundant sequence information permits a broad-based gene inactivation approach in C. elegans, in which chemically mutagenized nematode populations are screened by PCR for deletion mutations in a specific targeted gene. By handling mutagenized worm growth, genomic DNA templates, PCR screens, and mutant recovery ail in 96-well microtiter plates, we have scaled up this approach to isolate deletion mutations in >100 genes to date. Four chemical mutagens, including ethyl methane sulfonate, ethlynitrosourea, diepoxyoctane, and ultraviolet-activated trimethylpsoralen, induced detectable deletions at comparable Frequencies. The deletions averaged similar to 1400 bp in size when using a -3 kb screening window. The vast majority of detected deletions removed portions of one or more exons, likely resulting in loss of gene function. This approach requires only the knowledge of a target gene sequence and a suitable mutagen, and thus provides a scalable systematic approach to gene inactivation for any organism that can be handled in high density arrays.
引用
收藏
页码:859 / 867
页数:9
相关论文
共 35 条